To curb drug prices, Democrats still seeking a balance
WASHINGTON (AP) — Democrats are committed to passing legislation this year to curb prescription drug prices, but they’re still disagreeing on how to cut costs for patients and taxpayers while preserving profits that lure investors to back potentially promising treatments.
…what that company would demand from you—your money or your life—would be called a mugging.
In the bright light of day, it's just another day at the office for these Democrats.
I have a healthy respect for the role of investment in driving progress, and the fecklessness of bureaucracies at that same enterprise. But I don't see why the government, acting on behalf of taxpayers, can't be the investor here and pass the potential profits from that investing back to taxpayers in the form of lower prices. In fact, quite a few of these "potentially promising treatments" are built on government-funded research to begin with.
But of course, what we're really taking about here is who gets the big campaign contributions and hot investment tips from Pharma, and that's what no politician will ever give up.
Voluntarily.
No comments:
Post a Comment